Ibnsina Pharma made $806.6 million in revenues in the first nine months of 2022 and had $630.7 million in assets. In May 2022, Ibnsina Pharma signed a contract to acquire El Shorouk Hospital in El Shorouk City in Egypt. Mahgoub has over 40 years of experience in the healthcare sector. He is also a member of the Strategies and Execution Committee at the Egyptian Foundation for Research & Community Development.